I. Applications of Oxygen in Pharmaceuticals
1. Cell Culture and Bioreactions
• Oxygen is essential for cellular respiration and metabolism. In biopharmaceutical production (e.g., antibodies, vaccines), precise oxygen control maintains cell viability and promotes product synthesis.
• Certain enzymatic reactions (e.g., cholesterol oxidase-catalyzed reactions) rely on oxygen as a substrate; high-purity oxygen enhances reaction efficiency and specificity.
• High oxygen concentrations improve microbial metabolic efficiency in fermentation processes (e.g., glucose fermentation), increasing yield.
2. Chemical Synthesis and Process Optimization
• Oxygen acts as an oxidant in drug synthesis, accelerating reaction rates and improving yield. For example, enzymatic oxidation reactions (e.g., cholesterol oxidase-catalyzed reactions) depend on high-purity oxygen to ensure specificity and efficiency.
• Oxygen is used as a combustible gas auxiliary in ampoule sealing processes.
3. Environmental Control and Protection
• Oxygen regulates tank atmospheres in fermentation and cell culture to prevent contamination or oxidative stress.
• High-purity oxygen is used for drying medical equipment and cleaning sterile areas, ensuring pollution-free production environments.
4. Medical Applications
• Medical-grade oxygen (93%-99.5% purity) treats respiratory diseases (e.g., hypoxia, respiratory failure) and serves as the basis for hyperbaric oxygen therapy.
• Oxygen is required for producing pharmaceutical excipients (e.g., aerosol propellants).
II. Advantages of On-Site PSA Oxygen Systems as Oxygen Sources
1. Economic Efficiency and Cost Control
• On-Demand Supply: Customizable oxygen flow and purity match production needs, avoiding waste or shortages.
• Cost Reduction: Compared to liquid oxygen or cylinder oxygen, PSA eliminates transportation and inventory costs, offering lower long-term expenses.
2. Stable and Controlled Oxygen Quality
• High Purity: PSA technology produces oxygen with 90%-99.5% purity, meeting strict pharmaceutical requirements (e.g., high-purity oxygen for cell cultures).
• Real-Time Monitoring: Automated systems ensure continuous, stable oxygen supply with consistent pressure, preventing production disruptions or material loss.
3. Safety and Compliance
• Eliminated Storage Risks: On-site oxygen generation removes the need for hazardous tanks, reducing explosion/leak risks and aligning with GMP safety standards.
• Customized Adaptation: Flexible configurations meet diverse oxygen demands while complying with pharmacopoeia limits on impurities (e.g., moisture, oil, microbes).
4. Environmental Sustainability
• Low Energy Consumption: Advances in PSA technology reduce energy use, and zero emissions support green pharmaceutical practices.
• Carbon Footprint Reduction: Eliminating liquid oxygen transportation cuts carbon emissions, aiding pharmaceutical companies’ “dual carbon” goals.
5. Process Optimization and Efficiency
• Precise Control: Adjustable oxygen concentration and flow optimize parameters in cell culture, oxidation reactions, etc., enhancing product consistency.
• Compact Design: Space-saving PSA units fit constrained factory layouts, and modular designs facilitate scalability.







